Congress to Clinic: Continual Evolution of HER3 Targeting in NSCLC With Expert Perspectives on Clinical Advances and Practical Application

Explore expert insights on the newest data on use of HER3-targeted therapy for patients with advanced NSCLC. Listen to podcasts derived from a live event, and download the accompanying slides for a comprehensive reference on the latest advancements in clinical trials.

Share

Program Content

Activities

HER3-Targeted Therapy in NSCLC
Congress to Clinic: Continual Evolution of HER3-Targeting in NSCLC With Expert Perspectives on Clinical Advances and Practical Application
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 17, 2023

Activities

HER3 Trials in NSCLC
Unpacking the Potential of HER3-Targeted Therapy in NSCLC
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2023

AE Management for HER3-Targeted Tx
Current Considerations for Adverse Event Management With HER3-Directed Agents
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2023

Rationale for Targeting HER3 in NSCLC
Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.